Graines Voltz S.A (GRVO)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 15.60 |
|---|---|
| 52-week range | 15.00 – 21.00 |
| Return, 1 month / 3 months | −5.5% / −13.3% |
| Return, 1 year / 3 years | −18.8% / −29.9% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -28.6% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Graines Voltz is a French horticultural company that produces and distributes vegetable and flower seeds, along with young plants and seedlings. It serves professional growers, market gardeners and horticultural businesses, supplying them with seed varieties and related plant products. The company is based in Alsace, in eastern France, and also offers horticultural supplies and services to its customers. Its work centres on plant breeding, seed production and the distribution of young plants to the professional horticulture trade.
The shares are listed on the Euronext Paris in France under the code GRVO, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Graines Voltz S.A (GRVO) trades on the Euronext Paris in France. It last closed at EUR 15.60 on 19 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 412 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.8% and over the last three months it fell 13.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 40 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.0% | ||
| From 52-week high | -25.7% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -13.3% | ||
| 6-month return | -20.8% | ||
| 12-month return, skipping the last month | -14.1% | ||
| Risk (lower is better) | 60 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 35.3% | ||
| Worst drawdown (1 year) | -28.6% | ||
| Liquidity | 29 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | −5.5% |
| 3 months | −13.3% |
| 6 months | −20.8% |
| 1 year | −18.8% |
| 3 years | −29.9% |
| 5 years | −87.5% |
Signals
| 50-day / 200-day average | 16.98 / 18.36 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Mar 2022 | EUR 2.0000 |
| 24 Mar 2020 | EUR 7.0000 |
| 27 Mar 2019 | EUR 6.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.